Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-034946

Chairman and CEO bought 5,700 shares at an average $1.60 ($9,127)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-06-04 Purchase +2,500 $1.59 $3,975 10,653,993 D
Niihara Yutaka Chairman and CEO 2020-06-05 Purchase +3,200 $1.61 $5,152 10,657,193 D
Open-market purchases · 5,700 sh · avg $1.60 · $9,127
Loading xslF345X03/doc4.xml…